Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition
Acquisition
Wall Street Analysts Predict a 42.77% Upside in DarioHealth (DRIO): Here's What You Should Know
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced the addition of six...
Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care
Customers
DarioHealth and OneStep Announce Strategic Collaboration to Integrate Smartphone-Only, Clinical-Grade Fall Risk Assessment Technology into Dario's Digital Health Multi-Condition Platform
Partners
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, and OneStep, the U.S. Food and Drug...
Partners
DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest
PIPEInvestment
DarioHealth Weighs Big Moves After Surprise Interest From Suitors
PartnersInvestmentPIPEManagement Changes
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in digital health solutions for chronic condition management, today...
InvestmentPIPEPartners
DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules
PIPE
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a private placement...
Investment
DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market
CustomersPartners
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today issued a shareholder update...
CustomersPartners
Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025
CustomersProduct Stage
DarioHealth Announces 20-to-1 Reverse Stock Split
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced that a reverse stock...
Some Analysts Just Cut Their DarioHealth Corp. (NASDAQ:DRIO) Estimates
Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk
Global Digital Therapeutics Market Experiencing Rapid Growth at a CAGR of ~28% by 2032 Amid Rising Demand for Personalized Healthcare| DelveInsight
DarioHealth Corp. (DRIO) Reports Q2 Loss, Misses Revenue Estimates
+ 201 more articles